Blog · APR 5, 2024 · 4 min read
Why Global Pharma CRMs Get India Wrong
Global pharma CRMs assume 6-8 calls a day and steady 4G; Indian reps average 12-16 calls on patchy connectivity, and adoption stalls below 60%.
Most pharma CRMs sold in India were designed in Boston or Paris for a rep who visits 6 doctors a day, carries a tablet with reliable 4G, and works a territory the size of a large hospital campus. The Indian medical rep visits 12 to 16 doctors a day, across a territory that can span 40 kilometres of mixed urban and semi-urban terrain, and loses connectivity for stretches of the working day that would be unthinkable in the reference markets these products were built for.
The territory math doesn't translate
A global CRM's call-planning module assumes call frequency of once every 2-3 weeks per doctor. Indian field teams often need weekly or twice-weekly touches because doctor loyalty is more fluid and competitor rep density is higher, in metro therapy areas like cardiology or diabetes, we've seen 5-7 competing reps calling on the same doctor within a single week. A system that caps daily call logging at 8-10 visits, which is standard in most western-built CRMs, forces reps to either under-report or work around the tool entirely.
Offline-first isn't a checkbox, it's the whole architecture
Global platforms treat offline mode as a fallback: cache the last sync, queue a few writes, reconcile later. That's adequate when connectivity drops for minutes. It fails when a rep works a six-hour stretch in a tier-3 town with no signal at all, then syncs 40 call reports at once over a flaky evening connection. We've watched implementations where sync conflicts silently drop 15-20% of a week's call data, and nobody notices until the monthly MIS report doesn't reconcile.
Compliance fields are an afterthought, not the default
UCPMP-style disclosure requirements, sample accountability, and gift-value caps are compliance realities that Indian pharma marketing teams live with daily. Global CRMs treat these as custom fields bolted on during implementation, which means every company reinvents the same audit trail from scratch, at a cost that often exceeds the license fee itself.
None of this means the global platforms are badly built. They're well built for a different job. The mismatch is a market-fit problem, not an engineering one, and it shows up first in adoption numbers. Field force CRM adoption in India frequently sits below 60% six months post-rollout, and the reason cited most often in exit interviews with reps isn't the interface. It's that the tool doesn't match how the day actually works.